Skip to main content
OpenTrials

Clinical trial condition

Respiratory Tract Diseases

Explore clinical trials studying Respiratory Tract Diseases. Study availability and eligibility vary by location and protocol.

309 public trials 36 recruiting studies
Refine in advanced search Browse all conditions

Respiratory Tract Diseases trial results

Completed

Immunogenicity, Safety, and Tolerability of a Plant-Derived Quadrivalent VLP Influenza Vaccine in Elderly Adults

NCT02831751

Conditions
Infections, Influenza, Human, Orthomyxoviridae Infections, +4 more
Locations
  • Paradigm Research - Redding Redding, California, United States
  • Broward Research Group (BRG) Hollywood, Florida, United States
  • Miami Research Associates (MRA) South Miami, Florida, United States
  • Meridian Clinical Research - Savannah Savannah, Georgia, United States
View all 15 locations
View Trial Details
Completed

A Safety Extension Study to Evaluate the Safety and Tolerability of Benralizumab (MEDI-563) in Asthmatic Adults and Adolescents on Inhaled Corticosteroid Plus LABA

NCT02258542

Conditions
Asthma, Bronchial Diseases, Hypersensitivity, +6 more
Locations
  • Research Site Andalusia, Alabama, United States
  • Research Site Birmingham, Alabama, United States
  • Research Site Scottsboro, Alabama, United States
  • Research Site Glendale, Arizona, United States
View all 429 locations
View Trial Details
Completed

Targeted Hypoglossal Neurostimulation Study #2

NCT01796925

Conditions
Apnea, Dyssomnias, Mental Disorders, +12 more
Locations
  • Sharp Rees Stealy Medical Center San Diego, California, United States
  • Porter Adventist Hospital Denver, Colorado, United States
  • Chicago ENT Chicago, Illinois, United States
  • Orange Regional Medical Center Middletown, New York, United States
View Trial Details
Completed

A Study of the Efficacy and Safety of NVA237 in Patients With Moderate to Severe COPD

NCT02371629

Conditions
Chronic Disease, Chronic Obstructive Pulmonary Disease, Disease Attributes, +6 more
Locations
  • Novartis Investigative Site Genk, Limburg, Belgium
  • Novartis Investigative Site Jambes, Namur, Belgium
  • Novartis Investigative Site Sevlievo, Gabrovo, Bulgaria
  • Novartis Investigative Site Sofia, Sofia-Grad, Bulgaria
View all 81 locations
View Trial Details
Completed

Safety and Tolerability Study of 2 Dose Level of Arikayce™ in Patients With Bronchiectasis and Chronic Infection Due to Pseudomonas Aeruginosa.

NCT00775138

Conditions
Bacterial Infections, Bacterial Infections and Mycoses, Bronchial Diseases, +7 more
Locations
  • Washington D.C., District of Columbia, United States
  • Philadelphia, Pennsylvania, United States
  • Sofia, Bulgaria
  • Athens, Greece
View all 18 locations
View Trial Details
Completed

Efficacy and Safety of Benralizumab in Moderate to Very Severe Chronic Obstructive Pulmonary Disease (COPD) With Exacerbation History

NCT02155660

Conditions
Bronchial Diseases, Chronic Disease, Disease Attributes, +7 more
Locations
  • Research Site Birmingham, Alabama, United States
  • Research Site Gulf Shores, Alabama, United States
  • Research Site Montgomery, Alabama, United States
  • Research Site Flagstaff, Arizona, United States
View all 356 locations
View Trial Details
Completed

Benralizumab Efficacy in Moderate to Very Severe Chronic Obstructive Pulmonary Disease (COPD) With Exacerbation History

NCT02138916

Conditions
Bronchial Diseases, Chronic Disease, Disease Attributes, +7 more
Locations
  • Research Site Andalusia, Alabama, United States
  • Research Site Birmingham, Alabama, United States
  • Research Site Birmingham, Alabama, United States
  • Research Site Dothan, Alabama, United States
View all 407 locations
View Trial Details
Completed

Fenzian Asthma Multicenter Outcomes Study

NCT00784758

Conditions
Asthma, Bronchial Diseases, Hypersensitivity, +6 more
Locations
  • University of California, Los Angeles Los Angeles, California, United States
  • Johns Hopkins University Baltimore, Maryland, United States
  • Duke University Medical Center Durham, North Carolina, United States
  • University of Cape Town Lung Institute Mowbray, Cape Town, South Africa
View Trial Details

Related conditions